MM

Mark Moore

Team Member

Circumvent Pharmaceuticals

Circumvent Pharmaceuticals Pipeline

DrugIndicationPhase
Undisclosed Therapeutic(s)CLN1 Batten Disease (PPT1 deficiency)Pre-clinical